<div>Dear friends, we are starting this fundraiser to collect funds to pay for the treatment costs of our Mum, Julie, who has stage 4 metastatic lung cancer and has exhausted all treatment options.
</div>
<div><br />
</div>
<div>A few days after Christmas in 2020 our mum noticed a small blur in her vision. Thinking it was probably nothing to fear, she visited her optometrist who expected that she had a detached retina, a very common and trivial-to-treat condition.
</div>
<div>Following a series of long and stressful tests our Mum, a non-smoking, otherwise healthy and active 54-year-old was diagnosed with late-stage HER2-positive lung cancer. As anyone reading this will imagine, this was a devastating shock to the whole family. Not just how out of the blue the diagnosis was, but the stage at which this disease presented itself, with no prior warning or symptoms.
</div>
<div><br />
</div>
<div>Over the last few years, Julie has received an onslaught of treatments, chemo, immunotherapy, and radiotherapy. As well as nominating herself for two early-stage drug trials. Despite this rollercoaster of treatment, our mum remains positive and continues to fight. As her family, all we’ve been able to offer is our company and emotional support. Needless to say, we’ve felt powerless throughout.
</div>
<div><br />
</div>
<div>During the initial stages of her treatment the mutation HER2 was identified. The HER2 mutation is very rare in lung cancer, affecting only about 3% of people with the disease. It hits indiscriminately but seems to be more prevalent in non-smoking, younger, and female people. Her oncologists have recommended a drug known as Enhertu - made by AstraZeneca and Daiichi Sankyo. Despite Enhertu being available, and widely so, for lung cancer patients in the US and breast cancer patients in the UK (via the NHS). This drug is not available on the NHS in the UK for those with lung cancer. 
</div>
<div><br />
</div>
<div>Enhertu has shown amazing promise in HER2+ <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2112431" target="_blank" rel="noreferrer noopener">lung cancer patients</a>. However, NICE (the body that approves drugs to be delivered on the NHS) has said they are still waiting for a submission by the pharmaceutical companies to allow this drug to be paid for by the NHS. When this will happen is a mystery and until then, and with no access to the drug on compassionate grounds, the NHS insists that patients wanting access to this breakthrough therapy will have to front the cost themselves – to an extraordinary personal cost. See here a petition calling on this drug to be fast-tracked to lung cancer patients (<a href="https://www.change.org/p/lung-cancer-patients-right-to-live?recruiter=1309778865&amp;utm_source=share_petition&amp;utm_campaign=psf_combo_share_initial&amp;utm_medium=whatsapp&amp;utm_content=washarecopy_36138054_en-GB%253A0&amp;recruited_by_id=374e5b20-0479-11ee-ab03-2508278bb0a9&amp;share_bandit_exp=initial-36138054-en-GB" target="_blank" rel="noreferrer noopener">sign here</a>).
</div>
<div><br />
</div>
<div>Julie has contacted both pharma companies, the NHS, NICE, and her local MP and multiple cancer centres. None have been able to or are willing to do anything for patients in her position. It is a travesty that drugs with known and measured benefits are not able to be used by patients who need them most.
</div>
<div><br />
</div>
<div>So, we are left with one option, pay for this therapy privately. This drug is being provided to lung cancer patients in the UK for £5000, for each treatment cycle. One treatment cycle every 3 weeks. We are not a wealthy family, and every penny of my family's savings is being spent on enabling our Mum to buy a little more time with her family. Mum has scheduled this treatment to be delivered at the Bristol Royal Infirmary in the UK. Cancer patients and their families often have to rely on hope and optimism even in the darkest of times. Hope that new therapies become available, hope that they respond a little better than the average person, and hope that they will be able to spend a little more time with their families and friends. Despite the miracle of modern medicine, sometimes hope is the only thing we have.
</div>
<div><br />
</div>
<div>Our hope is that one day all patients will have access to the best possible treatment for their disease and not be faced with these nightmarish decisions. Julie should be living the best part of her life right now but is forced to live this one instead.
</div>
<div><br />
</div>
<div>Any contribution, however small you are willing to donate to this cause will be appreciated. All donations will be going to the BRI to fund this last-resort treatment.
</div>
<div><br />
</div>
<div>Thank you for your kind donations and consideration.
</div>
<div><br />
</div>
<div><br />
</div>
<div><br />
</div>

Anonymous

Tracey Watts

Nazreen L Haslett

andrew swift

Michael Collins

TERESA Priest

Jack Lawrence

Alyson Vowles

Simon Stephens

Matthew Jones

Hazel Fuller

Jane Lawrence

Faye Pope

Jill Lewis

Sarah Munson

Kathryn White

Jean Chichester

Marjorie Lane

Eleanor Singer

Help get our Mum the cancer treatment she needs

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Help get our Mum the cancer treatment she needs

Still £4,520 to go. Help us build momentum.